TP53 and metastatic melanoma: However, because of their distinct roles in carcinogenesis, p53/p73 isoforms might be involved in developing resistance to targeted therapy in metastatic melanoma due to their aberrant expression, localization, and/or mutual inhibitory protein interactions.